Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ArriVent BioPharma, Inc.Listing on record | Sell | $13M | SEC | ||
ArriVent BioPharma, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ArriVent BioPharma, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ArriVent BioPharma, Inc.Listing on record | Buy | $10M | conv 62ClusterFirst in 12mo | SEC | |
ArriVent BioPharma, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
ArriVent BioPharma, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
BeOne Medicines Ltd.Listing on record | Sell | $129.2M | SEC | ||
BeOne Medicines Ltd.Listing on record | Sell | $56.9M | SEC | ||
BeOne Medicines Ltd.Listing on record | Sell | $40.2M | SEC | ||
BeOne Medicines Ltd.Listing on record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |